Global Vitamin B7 (Biotin) API Market Growth 2024-2030
Biotin is a water-soluble B-vitamin, also called vitamin B7 and formerly known as vitamin H or coenzyme R. It is composed of a ureido ring fused with a tetrahydrothiophene ring. A valeric acid substituent is attached to one of the carbon atoms of the tetrahydrothiophene ring. Biotin is a coenzyme for carboxylase enzymes, involved in the synthesis of fatty acids, isoleucine, and valine, and in gluconeogenesis.
The global Vitamin B7 (Biotin) API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Vitamin B7 (Biotin) API Industry Forecast” looks at past sales and reviews total world Vitamin B7 (Biotin) API sales in 2023, providing a comprehensive analysis by region and market sector of projected Vitamin B7 (Biotin) API sales for 2024 through 2030. With Vitamin B7 (Biotin) API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B7 (Biotin) API industry.
This Insight Report provides a comprehensive analysis of the global Vitamin B7 (Biotin) API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B7 (Biotin) API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vitamin B7 (Biotin) API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B7 (Biotin) API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B7 (Biotin) API.
Global biotin main players are Zhejiang Medicine, SDM, Hegno etc. Global top 2 manufacturers hold a share over 75%. Asia-Pacific is the largest market, with a share about 33%, followed by Europe and North America with the share about 30% and 25%.In terms of product, 2% biotin is the largest segment, with a share over 35%. And in terms of application, the largest application is animal feed.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B7 (Biotin) API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Food Grade
Feed Grade
Pharma Grade
Segmentation by Application:
Food
Pharma
Cosmetics
Animal Feed
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Zhejiang Medicine
SDM
Hegno
NUH
Anhui Tiger Biotech
Kexing Biochem
DSM
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vitamin B7 (Biotin) API market?
What factors are driving Vitamin B7 (Biotin) API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vitamin B7 (Biotin) API market opportunities vary by end market size?
How does Vitamin B7 (Biotin) API break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.